Research Paper Volume 15, Issue 10 pp 4444—4464

Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma

class="figure-viewer-img"

Figure 9. (AL) Therapeutic drugs showed significant differences in IC50 between the high- and low-risk groups.